Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2015 Jul 15;24(8):1262–1269. doi: 10.1158/1055-9965.EPI-15-0212

Figure 3.

Figure 3

Adjusted 4-year weight gain in survivors, stratified by time since diagnosis, treatment category, and BMI category at T1, compared to cancer-free women. Estimates for weight gain among (a) women with BMI between 18.5 kg/m2 and 25 kg/m2, (b) women with BMI ≥ 25 kg/m2, (c) survivors treated with chemotherapy and cancer-free women, with BMI between 18.5 kg/m2 and 25 kg/m2, (d) survivors treated with chemotherapy and cancer-free women, with BMI ≥ 25 kg/m2, (e) survivors treated with hormone therapy alone and cancer-free women, with BMI between 18.5 kg/m2 and 25 kg/m2, (f) survivors treated with hormone therapy alone and cancer-free women, with BMI ≥ 25 kg/m2.